# XELJANZ

NDC: 63539-029
Generic name: tofacitinib
Labeler / Manufacturer: U.S. Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION
Routes: ORAL
Marketing started: 20210208

FDA application: NDA213082

## Active ingredients

- TOFACITINIB CITRATE: 1 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63539-029"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63539-029
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=68e3d6b2-7838-4d2d-a417-09d919b43e13